Concepedia
Statistics
Publications
102
Citations
10.2K
H-Index
56
Active since
1992
Affiliations
The University of Sydney(Current)
Westmead Hospital
Melanoma Institute Australia
Westmead Institute
Macquarie University
Helen Rizos is an author at The University of Sydney specializing in oncology, molecular oncology, and medicine.
Publications per year
1992–2025
Distinct Immune Cell Populations Define Response to Anti-PD-1 Monotherapy and Anti-PD-1/Anti-CTLA-4 Combined Therapy
Tuba N. Gide, Camelia Quek, Alexander M. Menzies et al. · Cancer Cell · 2019 · 1K citations · Full text
Life Sciences, Immunology, Oncology +17
BRAF Inhibitor Resistance Mechanisms in Metastatic Melanoma: Spectrum and Clinical Impact
Helen Rizos, Alexander M. Menzies, Gulietta M. Pupo et al. · Clinical Cancer Research · 2014 · 542 citations
Medicine, Oncology, Pharmacology +17
Increased MAPK reactivation in early resistance to dabrafenib/trametinib combination therapy of BRAF-mutant metastatic melanoma
Georgina V. Long, Carina Fung, Alexander M. Menzies et al. · Nature Communications · 2014 · 387 citations · Full text
Circulating Cytokines Predict Immune-Related Toxicity in Melanoma Patients Receiving Anti-PD-1–Based Immunotherapy
Su Yin Lim, Jenny Lee, Tuba N. Gide et al. · Clinical Cancer Research · 2018 · 368 citations
Circulating tumor DNA to monitor treatment response and detect acquired resistance in patients with metastatic melanoma
Elin S. Gray, Helen Rizos, Anna Reid et al. · Oncotarget · 2015 · 329 citations · Full text
Medicine, Molecular Genetics, Oncology +17
1–5 of 102